LRMR / Larimar Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Larimar Therapeutics, Inc.
US ˙ NasdaqGM ˙ US5171251003

Deler fremragende 103,882,937 shares
Insideraktier17.751.280 shares
Insider ejerskab17,09 %
Total Insiders48
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier
Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier
Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
4617 out of 10916

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
4436 out of 10752

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Larimar Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet		 Dele
Justeret
Patricia L Allen Chief Financial Officer - [O] 19.793 19.793
Atlas Venture Associates VII, Inc. 10% Owner - [10%] 11 11
Atlas Venture Associates VII, L.P. 10% Owner - [10%] 11 11
Atlas Venture Fund VII L P 10% Owner - [10%] 11 11
Carole Ben-maimon President and CEO, Director - [D] [O] 524.054 524.054
Peter Barrett Director, 10% Owner - [D] [10%] 4.643.327 4.643.327
Bruce Booth Director, 10% Owner - [D] [10%] 4.638.028 4.638.028
Chondrial Therapeutics Holdings, Llc 10% Owner - [10%] 8 8
Michael Celano Chief Financial Officer - [O] 215.785 215.785
Russell Clayton Chief Medical Officer - [O] 71.443 71.443
Management Co Deerfield 10% Owner - [10%] 8.300 6.207.982
Deerfield Partners, L.p. 10% Owner - [10%] 5.555.554 6.207.982
Thomas O Daniel Director - [D] 19.452 19.452
Deerfield Healthcare Innovations Fund, L.P. Director, 10% Owner - [D] [10%] 1.943.420 6.207.982
Deerfield International Master Fund, L.P. 10% Owner - [10%] 1.151.802 1.151.802
Deerfield Mgmt HIF, L.P. Director, 10% Owner - [D] [10%] 1.943.420 6.207.982
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet		 Dele
Justeret
Deerfield Mgmt III, L.P. Director, 10% Owner - [D] [10%] 1.943.420 6.207.982
Deerfield Mgmt IV, L.P. Director, 10% Owner - [D] [10%] 1.943.420 6.207.982
Deerfield Mgmt L.P. 10% Owner - [10%] 1.151.802 6.207.982
Deerfield Private Design Fund III, L.P. Director, 10% Owner - [D] [10%] 1.943.420 6.207.982
Deerfield Private Design Fund IV, L.P. Director, 10% Owner - [D] [10%] 1.943.420 6.207.982
Deerfield Special Situations Fund, L.P. 10% Owner - [10%] 1.151.802 1.151.802
Wendy Everett 27.000
James E Flynn Director, 10% Owner - [D] [10%] 6.207.982 6.207.982
Goldberg Avi Y. Director - [D] 53.734 53.734
Thomas Edward Hamilton Director - [D] 664.798 664.798
Hatfield Jeffrey S. 525.000
Frances K Heller Director - [D] 47.961 47.961
Hughes Thomas E. See Remarks, Director - [D] [O] 125.247 125.247
Dennis D Kim Chief Medical Officer - [O] 21.443 21.443
John L Lamattina Director - [D] 31.376 31.376
Jonathan S Leff 8.300
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet		 Dele
Justeret
Mark J Levin 10% Owner - [10%] 0 0
Patrick Loustau 56.500
Cameron Geoffrey McDonough Director - [D] 0 0
Brian McVeigh 125.000
Robert J Perez Director - [D] 5.322 5.322
Jeffrey W Sherman Director - [D] 5.000 5.000
Kevin P Starr Director - [D] 370.323 370.323
Alicia Secor Chief Commercial Officer - [O] 0 0
Gopi Shankar Chief Development Officer - [O] 76.443 76.443
Priya Singhal 375.000
Robert I Tepper 10% Owner - [10%] 0 0
Third Rock Ventures Lp 10% Owner - [10%] 0 0
Frank E Thomas Director - [D] 7.000 7.000
Trv Gp, Llc 10% Owner - [10%] 0 0
Third Rock Ventures GP, L.P. 10% Owner - [10%] 0 0
Joseph Truitt Director - [D] 2.750 2.750

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i LRMR / Larimar Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier		 Rapporteret
Pris		 Justeret
Aktier		 Justeret
Pris		 Omkostningsgrundlag dage til
Maks		 Pris kl
Maks		 Maks
Fortjeneste ($)		 Maks. afkast (%)
2026-02-27 Flynn James E 2.000.000 5,0000 2.000.000 5,0000 10.000.000 10 5.6900 1.380.000 13,80
2026-02-27 Flynn James E 831.978 5,0000 831.978 5,0000 4.159.890
2026-02-27 Flynn James E 1.084.012 5,0000 1.084.012 5,0000 5.420.060
2026-02-27 Flynn James E 1.084.010 5,0000 1.084.010 5,0000 5.420.050
2026-02-27 THOMAS FRANK E 5.000 5,0000 5.000 5,0000 25.000
2026-02-27 SHERMAN JEFFREY W 5.000 5,0000 5.000 5,0000 25.000
2026-02-27 Hamilton Thomas Edward 100.000 5,0000 100.000 5,0000 500.000
2025-07-31 Flynn James E 2.599.932 3,2000 2.599.932 3,2000 8.319.782
2025-07-31 Flynn James E 3.387.539 3,2000 3.387.539 3,2000 10.840.125

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LRMR / Larimar Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i LRMR / Larimar Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier		 Rapporteret
Pris		 Justeret
Aktier		 Justeret
Pris		 Omkostningsgrundlag dage til
Min		 Pris kl
Min		 Max tab
Undgået ($)		 Max tab
Undgået (%)
2016-07-20 Flynn James E 901.430 3,3118 901.430 3,3118 2.985.356 8
2016-07-20 Flynn James E 246.439 3,3118 246.439 3,3118 816.157
2016-07-20 Flynn James E 193.630 3,3118 193.630 3,3118 641.264
2015-09-24 STARR KEVIN P 61.630 44,1000 61.630 44,1000 2.717.883
2015-09-24 STARR KEVIN P 74.949 43,7300 74.949 43,7300 3.277.520
2015-09-17 KIM DENNIS D 9.142 40,0000 9.142 40,0000 365.680
2015-09-15 KIM DENNIS D 30.265 40,0000 30.265 40,0000 1.210.600
2015-09-14 KIM DENNIS D 593 40,0000 593 40,0000 23.720

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LRMR / Larimar Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato		 Handle
Dato		 Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris		 Enhed
Pris		 Enheder
Ændret		 Værdi
Ændret (1K)		 Tilbage
Muligheder		 Tilbage
Aktier
2026-03-02 2026-02-27 4 Flynn James E Through Deerfield Partners, L.P. LRMR Common Stock P - Purchase I 5,0000 2.000.000 10.000 6.207.982
2026-03-02 2026-02-27 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. LRMR Common Stock P - Purchase I 5,0000 831.978 4.160 8.153.107
2026-03-02 2026-02-27 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. LRMR Common Stock P - Purchase I 5,0000 1.084.012 5.420 10.622.957
2026-03-02 2026-02-27 4 Flynn James E Through Deerfield Private Design Fund III, L.P. LRMR Common Stock P - Purchase I 5,0000 1.084.010 5.420 10.622.928
2026-03-02 2026-02-27 4 Hamilton Thomas Edward LRMR Common Stock P - Purchase D 5,0000 100.000 500 664.798
2026-03-02 2026-02-27 4 SHERMAN JEFFREY W LRMR Common Stock P - Purchase D 5,0000 5.000 25 5.000
2026-03-02 2026-02-27 4 THOMAS FRANK E LRMR Common Stock P - Purchase D 5,0000 5.000 25 7.000
2026-01-27 2026-01-26 4 BEN-MAIMON CAROLE LRMR Common Stock A - Award D 100.100 368.276
2026-01-27 2026-01-26 4 Clayton Russell LRMR Common Stock A - Award D 25.637 71.443
2026-01-27 2026-01-26 4 Shankar Gopi LRMR Common Stock A - Award D 25.637 76.443
2026-01-27 2026-01-26 4 Celano Michael LRMR Common Stock A - Award D 37.604 215.785
2025-08-04 2025-07-31 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. LRMR Common Stock P - Purchase I 3,2000 2.599.932 8.320 7.321.129
2025-08-04 2025-07-31 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. LRMR Common Stock P - Purchase I 3,2000 3.387.539 10.840 9.538.945
2025-08-04 2025-07-31 4 Flynn James E Through Deerfield Private Design Fund III, L.P. LRMR Common Stock P - Purchase I 3,2000 3.387.529 10.840 9.538.918
2025-01-24 2025-01-22 4 Clayton Russell LRMR Common Stock A - Award D 23.306 45.806
2025-01-24 2025-01-22 4 Shankar Gopi LRMR Common Stock A - Award D 23.306 50.806
2025-01-24 2025-01-22 4 BEN-MAIMON CAROLE LRMR Common Stock A - Award D 91.000 387.208
2025-01-24 2025-01-22 4 Celano Michael LRMR Common Stock A - Award D 34.185 178.181
2024-05-31 2024-02-16 4 Hamilton Thomas Edward LRMR Common Stock P - Purchase D 8,7400 57.208 500 564.798
2024-02-16 2024-02-16 4 Flynn James E Through Deerfield Partners, L.P. LRMR Common Stock P - Purchase I 8,7400 1.430.205 12.500 4.207.982
2024-02-16 2024-02-16 4 Flynn James E Through Deerfield Private Design Fund III, L.P. LRMR Common Stock P - Purchase I 8,7400 1.430.206 12.500 6.151.406
2024-02-16 2024-02-16 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. LRMR Common Stock P - Purchase I 8,7400 1.430.206 12.500 6.151.406
2024-02-15 2024-02-14 4 THOMAS FRANK E LRMR Common Stock P - Purchase D 11,0000 2.000 22 2.000
2024-01-19 2024-01-17 4 Shankar Gopi LRMR Common Stock A - Award D 22.500 27.500
2024-01-19 2024-01-17 4 Celano Michael LRMR Common Stock A - Award D 31.250 143.996
2024-01-19 2024-01-17 4 BEN-MAIMON CAROLE LRMR Common Stock A - Award D 66.125 332.954
2024-01-19 2024-01-17 4 Clayton Russell LRMR Common Stock A - Award D 22.500 22.500
2023-12-08 2023-12-07 4 Shankar Gopi LRMR Common Stock P - Purchase D 3,7323 5.000 19 5.000
2023-05-18 2023-05-17 4 BEN-MAIMON CAROLE LRMR Common Stock P - Purchase D 3,7050 5.000 19 266.829
2023-05-18 2023-05-17 4 Celano Michael LRMR Common Stock P - Purchase D 3,7263 5.000 19 112.746
2023-05-18 2023-05-17 4 Truitt Joseph LRMR Common Stock P - Purchase D 3,7300 2.750 10 2.750
2023-02-02 2023-01-31 4 Celano Michael LRMR Common Stock A - Award D 76.000 107.746
2023-02-02 2023-01-31 4 BEN-MAIMON CAROLE LRMR Common Stock A - Award D 205.000 261.829
2022-09-20 3 Deerfield Mgmt L.P. LRMR Common Stock D 2.777.777
2022-09-20 2022-09-16 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. LRMR Common Stock P - Purchase I 3,1500 2.777.777 8.750 2.777.777
2022-09-20 2022-09-16 4 Flynn James E Through Deerfield Private Design Fund III, L.P. LRMR Common Stock P - Purchase I 3,1500 2.777.777 8.750 2.777.777
2022-09-20 2022-09-16 4 Flynn James E Through Deerfield Partners, L.P. LRMR Common Stock P - Purchase I 3,1500 2.777.777 8.750 2.777.777
2022-09-20 2022-09-16 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. LRMR Common Stock P - Purchase I 3,1500 2.777.777 8.750 2.777.777
2022-09-20 2022-09-16 4 Hamilton Thomas Edward LRMR Common Stock P - Purchase D 3,1500 317.460 1.000 507.590
2022-09-19 2022-09-16 4 BEN-MAIMON CAROLE LRMR Common Stock P - Purchase D 3,1500 31.746 100 56.829
2022-09-19 2022-09-16 4 Celano Michael LRMR Common Stock P - Purchase D 3,1500 31.746 100 31.746
2022-05-12 2022-05-10 4 Truitt Joseph LRMR Stock Option (Right to Buy) A - Award D 2,92 8.300 8.300
2022-05-12 2022-05-10 4 LEFF JONATHAN S LRMR Stock Option (Right to Buy) A - Award D 2,92 8.300 8.300
2022-05-12 2022-05-10 4 Celano Michael LRMR Stock Option (Right to Buy) A - Award D 2,92 20.000 20.000
2022-05-12 2022-05-10 4 BEN-MAIMON CAROLE LRMR Stock Option (Right to Buy) A - Award D 2,92 40.000 40.000
2022-05-12 2022-05-10 4 THOMAS FRANK E LRMR Stock Option (Right to Buy) A - Award D 2,92 8.300 8.300
2022-05-12 2022-05-10 4 Barrett Peter LRMR Stock Option (Right to Buy) A - Award D 2,92 8.300 8.300
2022-05-12 2022-05-10 4 Hamilton Thomas Edward LRMR Stock Option (Right to Buy) A - Award D 2,92 8.300 8.300
2022-05-11 2022-05-10 4 Flynn James E Through Deerfield Management Company, L.P. LRMR Stock Option (Right to Buy) A - Award I 2,92 8.300 8.300
2022-01-20 2022-01-18 4 Celano Michael LRMR Stock Option (Right to Buy) A - Award D 8,75 80.000 80.000
2022-01-20 2022-01-18 4 BEN-MAIMON CAROLE LRMR Stock Option (Right to Buy) A - Award D 8,75 182.000 182.000
2021-07-02 2021-06-30 4 Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. LRMR Common Stock P - Purchase I 8,7500 228.570 2.000 1.943.420
2021-07-02 2021-06-30 4 Flynn James E Through Deerfield Private Design Fund IV, L.P. LRMR Common Stock P - Purchase I 8,7500 228.571 2.000 1.943.423
2021-07-02 2021-06-30 4 Flynn James E Through Deerfield Private Design Fund III, L.P. LRMR Common Stock P - Purchase I 8,7500 228.569 2.000 1.943.406
2021-07-02 2021-06-30 4 Hamilton Thomas Edward LRMR Common Stock P - Purchase D 8,7500 56.710 496 190.130
2021-05-20 2021-05-12 4 Truitt Joseph LRMR Stock Option (right to buy) A - Award D 10,34 8.300 8.300
2021-05-17 2021-05-12 4 Hamilton Thomas Edward LRMR Stock Option (right to buy) A - Award D 10,34 8.300 8.300
2021-05-17 2021-05-12 4 Daniel Thomas O LRMR Stock Option (right to buy) A - Award D 10,34 8.300 8.300
2021-05-17 2021-05-12 4 THOMAS FRANK E LRMR Stock Option (right to buy) A - Award D 10,34 8.300 8.300
2021-05-17 2021-05-12 4 Barrett Peter LRMR Stock Option (right to buy) A - Award D 10,34 8.300 8.300
2021-05-17 2021-05-12 4 LEFF JONATHAN S LRMR Stock Option (right to buy) A - Award D 10,34 8.300 8.300
2021-05-17 2021-05-12 4 Flynn James E Through Deerfield Management Company, L.P. LRMR Stock Option (Right to Buy) A - Award I 10,34 8.300 8.300
2021-01-21 2021-01-19 4 BEN-MAIMON CAROLE LRMR Stock Option (Right to Buy) A - Award D 19,61 106.700 106.700
2021-01-21 2021-01-19 4 Celano Michael LRMR Stock Option (Right to Buy) A - Award D 19,61 42.000 42.000
2020-10-01 2020-09-29 4 Flynn James E Through Deerfield Management Company, L.P. LRMR Stock Option (Right to Buy) A - Award I 11,90 16.600 16.600
2020-09-30 2020-09-29 4 Hamilton Thomas Edward LRMR Stock Option (right to buy) A - Award D 11,90 16.600 16.600
2020-09-30 2020-09-29 4 Daniel Thomas O LRMR Stock Option (right to buy) A - Award D 11,90 16.600 16.600
2020-09-30 2020-09-29 4 Barrett Peter LRMR Stock Option (right to buy) A - Award D 11,90 16.600 16.600
2020-09-30 2020-09-29 4 Celano Michael LRMR Stock Option (right to buy) A - Award D 11,90 84.100 84.100
2020-09-30 2020-09-29 4 Truitt Joseph LRMR Stock Option (right to buy) A - Award D 11,90 16.600 16.600
2020-09-30 2020-09-29 4 LEFF JONATHAN S LRMR Stock Option (right to buy) A - Award D 11,90 16.600 16.600
2020-09-30 2020-09-29 4 THOMAS FRANK E LRMR Stock Option (right to buy) A - Award D 11,90 16.600 16.600
2020-09-30 2020-09-29 4 BEN-MAIMON CAROLE LRMR Stock Option (right to buy) A - Award D 11,90 411.400 411.400
2020-06-30 2020-06-26 4 BEN-MAIMON CAROLE LRMR Common Stock J - Other D 25.083 25.083
2020-06-30 2020-06-26 4 CHONDRIAL THERAPEUTICS HOLDINGS, LLC LRMR Common Stock J - Other D -6.091.242 8
2020-06-30 2020-06-26 4 Hamilton Thomas Edward FA Life Sciences, Inc. LRMR Common Stock J - Other I 159.433 292.853
2020-06-30 2020-06-26 4 Hamilton Thomas Edward LRMR Common Stock J - Other D 133.420 133.420
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-08 3 Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC LRMR Common Stock I 12.182.500
2020-06-05 2020-05-28 4 Celano Michael LRMR Stock Option (Right to Buy) A - Award D 11,88 60.479 60.479
2020-06-05 3 CHONDRIAL THERAPEUTICS HOLDINGS, LLC LRMR Common Stock D 12.182.500
2020-06-05 3 CHONDRIAL THERAPEUTICS HOLDINGS, LLC LRMR Common Stock D 12.182.500
2020-06-05 3 CHONDRIAL THERAPEUTICS HOLDINGS, LLC LRMR Common Stock D 12.182.500
2019-06-27 2019-06-26 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 1,25 27.000 27.000
2019-06-27 2019-06-26 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 1,25 27.000 27.000
2019-06-27 2019-06-26 4 EVERETT WENDY ZFGN Stock Option (Right to Buy) A - Award D 1,25 27.000 27.000
2019-06-27 2019-06-26 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 1,25 27.000 27.000
2019-06-27 2019-06-26 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 1,25 27.000 27.000
2019-06-27 2019-06-26 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 1,25 27.000 27.000
2019-06-27 2019-06-26 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 1,25 27.000 27.000
2019-04-04 2019-04-02 4 Singhal Priya ZFGN Stock Option (Right to Buy) A - Award D 2,89 375.000 375.000
2019-01-28 2019-01-24 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 4,38 21.396 21.396
2019-01-28 2019-01-24 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 4,38 11.804 11.804
2019-01-28 2019-01-24 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 4,38 13.280 13.280
2019-01-28 2019-01-24 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 4,38 5.717 5.717
2019-01-28 2019-01-24 4 PEREZ ROBERT J ZFGN Common Stock A - Award D 4,3800 4.423 19 5.322
2019-01-28 2019-01-24 4 LAMATTINA JOHN L ZFGN Common Stock A - Award D 4,3800 10.844 47 31.376
2019-01-24 2019-01-22 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 4,63 125.000 125.000
2019-01-24 2019-01-22 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 4,63 95.000 95.000
2019-01-24 2019-01-22 4 Hatfield Jeffrey S. ZFGN Stock Option (Right to Buy) A - Award D 4,63 525.000 525.000
2019-01-24 2019-01-22 4 McVeigh Brian ZFGN Stock Option (Right to Buy) A - Award D 4,63 125.000 125.000
2018-07-02 2018-06-29 4 Atlas Venture Fund VII L P ZFGN Common Stock J - Other D -234.321 11
2018-07-02 2018-06-29 4 Atlas Venture Fund VII L P ZFGN Common Stock J - Other D -1.126.546 3.506.184
2018-06-29 2018-06-28 4 Hughes Thomas E. ZFGN Common Stock S - Sale D 10,0000 -32.000 -320 125.247
2018-06-07 2018-06-06 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 6,79 20.000 20.000
2018-06-07 2018-06-06 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 6,79 20.000 20.000
2018-06-07 2018-06-06 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 6,79 20.000 20.000
2018-06-07 2018-06-06 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 6,79 20.000 20.000
2018-06-07 2018-06-06 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 6,79 20.000 20.000
2018-06-07 2018-06-06 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 6,79 20.000 20.000
2018-06-07 2018-06-06 4 EVERETT WENDY ZFGN Stock Option (Right to Buy) A - Award D 6,79 40.000 40.000
2018-06-07 2018-06-06 4 EVERETT WENDY ZFGN Stock Option (Right to Buy) A - Award D 6,79 20.000 20.000
2018-05-30 2018-05-29 4 McVeigh Brian ZFGN Stock Option (Right to Buy) A - Award D 6,46 225.000 225.000
2018-03-09 2018-03-07 4 Hughes Thomas E. ZFGN Common Stock S - Sale D 10,0000 -5.000 -50 157.247
2018-02-23 2018-02-22 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 7,77 125.000 125.000
2018-02-23 2018-02-22 4 Hatfield Jeffrey S. ZFGN Stock Option (Right to Buy) A - Award D 7,77 275.000 275.000
2018-02-23 2018-02-22 4 Hughes Thomas E. ZFGN Stock Option (right to buy) A - Award D 7,77 275.000 275.000
2018-02-23 2018-02-22 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 7,77 125.000 125.000
2018-01-05 2018-01-03 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 5,18 9.421 9.421
2018-01-05 2018-01-03 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 5,18 9.725 9.725
2018-01-05 2018-01-03 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 5,18 8.509 8.509
2018-01-05 2018-01-03 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 5,18 17.627 17.627
2018-01-05 2018-01-03 4 LAMATTINA JOHN L ZFGN Common Stock A - Award D 5,1800 9.169 47 20.532
2018-01-05 2018-01-03 4 Daniel Thomas O ZFGN Common Stock A - Award D 5,1800 8.687 45 19.452
2017-12-29 2017-12-29 4 Hatfield Jeffrey S. ZFGN Stock Option (Right to Buy) A - Award D 3,40 1.100.000 1.100.000
2017-10-17 2017-10-13 4 Heller Frances K ZFGN Common Stock P - Purchase D 3,8988 10.000 39 47.961
2017-10-11 2017-10-09 4 Hughes Thomas E. ZFGN Employee Stock Option (right to buy) A - Award D 3,40 275.000 275.000
2017-10-11 2017-10-09 4 Hatfield Jeffrey S. ZFGN Stock Option (Right to Buy) A - Award D 3,40 550.000 550.000
2017-07-12 2017-07-11 4 KIM DENNIS D ZFGN Common Stock P - Purchase D 3,3900 10.000 34 21.443
2017-06-23 2017-06-21 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 3,95 14.500 14.500
2017-06-23 2017-06-21 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 3,95 14.500 14.500
2017-06-23 2017-06-21 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 3,95 14.500 14.500
2017-06-23 2017-06-21 4 Heller Frances K ZFGN Stock Option (Right to Buy) A - Award D 3,95 14.500 14.500
2017-06-23 2017-06-21 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 3,95 14.500 14.500
2017-06-23 2017-06-21 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 3,95 14.500 14.500
2017-06-23 2017-06-21 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 3,95 14.500 14.500
2017-06-23 2017-06-21 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 3,95 14.500 14.500
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,82 -68.073 0
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,75 -6.210 0
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy M - Exercise D 0,75 -18.928 0
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,8200 68.073 56 157.371
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 6.210 5 89.298
2017-05-15 2017-05-11 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 18.928 14 83.088
2017-05-11 2017-05-11 4 KIM DENNIS D ZFGN Common Stock P - Purchase D 4,4000 9.800 43 11.443
2017-05-11 2017-05-10 4 KIM DENNIS D ZFGN Common Stock P - Purchase D 4,4000 200 1 1.643
2017-02-14 2017-02-13 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 4,18 12.003 12.003
2017-02-14 2017-02-13 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 4,18 13.718 13.718
2017-02-14 2017-02-13 4 Daniel Thomas O ZFGN Common Stock A - Award D 4,1800 10.765 45 10.765
2017-02-14 2017-02-13 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 4,18 13.289 13.289
2017-02-14 2017-02-13 4 LAMATTINA JOHN L ZFGN Common Stock A - Award D 4,1800 11.363 47 11.363
2017-02-14 2017-02-13 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 4,18 24.864 24.864
2017-01-31 2017-01-27 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 4,05 88.000 88.000
2017-01-31 2017-01-27 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 4,05 88.000 88.000
2017-01-31 2017-01-27 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) A - Award D 4,05 319.000 319.000
2016-12-20 2016-12-19 4 Heller Frances K ZFGN Common Stock P - Purchase D 3,2290 10.000 32 30.000
2016-11-17 2016-11-15 4 Heller Frances K ZFGN Common Stock P - Purchase D 3,5434 10.000 35 20.000
2016-08-31 2016-08-29 4 Hughes Thomas E. ZFGN Common Stock P - Purchase D 2,9987 10.000 30 63.936
2016-08-01 2016-07-20 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock S - Sale I 3,3118 -901.430 -2.985 1.151.802
2016-08-01 2016-07-20 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock S - Sale I 3,3118 -246.439 -816 314.889
2016-08-01 2016-07-20 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock S - Sale I 3,3118 -193.630 -641 247.413
2016-07-26 2016-07-26 4 Allen Patricia L ZFGN Common Stock P - Purchase D 3,1500 8.200 26 19.793
2016-07-26 2016-07-25 4 Allen Patricia L ZFGN Common Stock P - Purchase D 3,0810 7.800 24 11.593
2016-07-26 2016-07-22 4 Heller Frances K ZFGN Common Stock P - Purchase D 2,9900 10.000 30 10.000
2016-07-26 2016-07-22 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,75 25.000 18.928
2016-07-26 2016-07-22 4 Hughes Thomas E. ZFGN Common Stock P - Purchase D 3,0208 5.000 15 53.936
2016-07-26 2016-07-22 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 25.000 19 48.936
2016-07-01 2016-06-30 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 5,99 12.000 12.000
2016-07-01 2016-06-30 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 5,99 12.000 12.000
2016-07-01 2016-06-30 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 5,99 12.000 12.000
2016-07-01 2016-06-30 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 5,99 12.000 12.000
2016-07-01 2016-06-30 4 Heller Frances K ZFGN Stock Option (Right to Buy) A - Award D 5,99 12.000 12.000
2016-07-01 2016-06-30 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 5,99 12.000 12.000
2016-07-01 2016-06-30 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 5,99 12.000 12.000
2016-07-01 2016-06-30 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 5,99 12.000 12.000
2016-04-12 2016-01-07 4 PEREZ ROBERT J See note ZFGN Common Stock A - Award I 6,2900 5.564 35 5.564
2016-04-04 2016-03-31 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 6,68 36.000 36.000
2016-04-04 2016-03-31 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 6,68 72.000 72.000
2016-04-04 2016-03-31 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 6,68 37.500 37.500
2016-04-04 2016-03-31 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 6,68 75.000 75.000
2016-04-04 2016-04-01 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 6,70 3.841 3.841
2016-04-04 2016-04-01 4 Daniel Thomas O ZFGN Stock Option (Right to Buy) A - Award D 6,70 24.000 24.000
2016-04-04 2016-04-01 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 7,91 6.100 6.100
2016-04-04 2016-04-01 4 McDonough Cameron Geoffrey ZFGN Common Stock D - Sale to Issuer D 7,9100 -4.424 -35 0
2016-04-04 2016-03-31 4 Secor Alicia ZFGN Stock Option (Right to Buy) A - Award D 6,68 -26.500 26.500
2016-04-04 2016-03-31 4 Secor Alicia ZFGN Stock Option (Right to Buy) A - Award D 6,68 -53.000 53.000
2016-04-04 2016-03-31 4 Loustau Patrick ZFGN Stock Option (Right to Buy) A - Award D 6,68 56.500 56.500
2016-04-04 2016-03-31 4 Loustau Patrick ZFGN Stock Option (Right to Buy) A - Award D 6,68 113.000 113.000
2016-04-04 2016-03-31 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) A - Award D 6,68 124.500 124.500
2016-04-04 2016-03-31 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) A - Award D 6,68 249.000 249.000
2016-02-17 2016-02-12 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock P - Purchase I 6,2466 13.872 87 2.053.232
2016-02-17 2016-02-12 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock P - Purchase I 6,2466 28.377 177 561.328
2016-02-17 2016-02-12 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock P - Purchase I 6,2466 22.296 139 441.043
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3.049.910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4.705.436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3.138.914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3.049.910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4.705.436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3.049.910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3.049.910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4.705.436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3.138.914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3.049.910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4.705.436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3.138.914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3.049.910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4.705.436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3.138.914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4.705.436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3.138.914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3.138.914
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. ZFGN Common Stock I 3.049.910
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock I 4.705.436
2016-02-11 3 Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. ZFGN Common Stock I 3.138.914
2016-02-11 2016-02-11 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock P - Purchase I 6,1884 504 3 2.039.360
2016-02-11 2016-02-11 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock P - Purchase I 6,1884 1.030 6 532.951
2016-02-11 2016-02-11 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock P - Purchase I 6,1884 810 5 418.747
2016-02-11 2016-02-10 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock P - Purchase I 6,2323 32.501 203 2.038.856
2016-02-11 2016-02-10 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock P - Purchase I 6,2323 66.486 414 531.921
2016-02-11 2016-02-10 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock P - Purchase I 6,2323 52.239 326 417.937
2016-02-11 2016-02-09 4 Flynn James E Through Deerfield Special Situations Fund, L.P. ZFGN Common Stock P - Purchase I 5,7291 24.484 140 2.006.355
2016-02-11 2016-02-09 4 Flynn James E Through Deerfield International Master Fund, L.P. ZFGN Common Stock P - Purchase I 5,7291 50.086 287 465.435
2016-02-11 2016-02-09 4 Flynn James E Through Deerfield Partners, L.P. ZFGN Common Stock P - Purchase I 5,7291 39.353 225 365.698
2016-01-27 2016-01-25 4 Barrett Peter ZFGN Common Stock A - Award D 7,9100 8.849 70 4.643.327
2016-01-27 2016-01-25 4 McDonough Cameron Geoffrey ZFGN Common Stock A - Award D 7,9100 4.424 35 4.424
2016-01-27 2016-01-25 4 Booth Bruce ZFGN Common Stock A - Award D 7,9100 4.424 35 4.638.028
2016-01-27 2016-01-25 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 7,91 9.150 9.150
2016-01-08 2016-01-08 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,75 -10.000 43.928
2016-01-08 2016-01-08 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 10.000 8 21.320
2015-10-30 2015-10-28 4 PEREZ ROBERT J ZFGN Common Stock A - Award D 10,4500 899 9 899
2015-10-30 2015-10-28 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 10,45 1.207 1.207
2015-10-20 2015-09-14 4/A KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 -593 -24 0
2015-10-20 2015-09-17 4/A KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 -9.142 -366 0
2015-10-20 2015-09-15 4/A KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 -30.265 -1.211 0
2015-09-28 2015-09-24 4 McDonough Cameron Geoffrey ZFGN Stock Option (Right to Buy) A - Award D 40,56 24.000 24.000
2015-09-28 2015-09-24 4 PEREZ ROBERT J ZFGN Stock Option (Right to Buy) A - Award D 40,56 24.000 24.000
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock J - Other D 98.834 370.323
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock J - Other I -476.170 0
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock J - Other I 476.170 476.170
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock S - Sale I 44,1000 -61.630 -2.718 210.371
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock S - Sale I 43,7300 -74.949 -3.278 272.001
2015-09-25 2015-09-24 4 STARR KEVIN P ZFGN Common Stock J - Other I -1.655.095 346.950
2015-09-24 2015-09-23 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 0,75 -10.500 53.928
2015-09-24 2015-09-23 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 0,7500 10.500 8 11.320
2015-09-21 2015-09-18 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 2,45 -23.126 160.555
2015-09-21 2015-09-18 4 Hughes Thomas E. ZFGN Common Stock S - Sale D 45,0000 -23.126 -1.041 820
2015-09-21 2015-09-18 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 2,4500 23.126 57 23.946
2015-09-21 2015-09-17 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) M - Exercise D 2,45 -4.874 183.681
2015-09-21 2015-09-17 4 Hughes Thomas E. ZFGN Common Stock S - Sale D 40,0000 -22.500 -900 820
2015-09-21 2015-09-17 4 Hughes Thomas E. ZFGN Common Stock M - Exercise D 2,4500 4.874 12 23.320
2015-09-21 2015-09-18 4 Goldberg Avi Y. ZFGN Common Stock S - Sale D 45,0000 -5.000 -225 53.734
2015-09-21 2015-09-17 4 Secor Alicia ZFGN Stock Option (Right to Buy) M - Exercise D 9,67 -25.000 134.235
2015-09-21 2015-09-17 4 Secor Alicia ZFGN Common Stock S - Sale D 41,0500 -1.256 -52 0
2015-09-21 2015-09-17 4 Secor Alicia ZFGN Common Stock S - Sale D 41,0500 -25.000 -1.026 1.256
2015-09-21 2015-09-17 4 Secor Alicia ZFGN Common Stock M - Exercise D 9,6700 25.000 242 26.256
2015-09-17 2015-09-17 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) M - Exercise D 1,57 -9.142 103.312
2015-09-17 2015-09-17 4 KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 -9.142 -366 0
2015-09-17 2015-09-17 4 KIM DENNIS D ZFGN Common Stock M - Exercise D 1,5700 9.142 14 9.142
2015-09-17 2015-09-15 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) M - Exercise D 1,57 -30.265 112.454
2015-09-17 2015-09-15 4 KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 -30.265 -1.211 0
2015-09-17 2015-09-15 4 KIM DENNIS D ZFGN Common Stock M - Exercise D 1,5700 30.265 48 30.265
2015-09-16 2015-09-14 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) M - Exercise D 1,57 -593 142.719
2015-09-16 2015-09-14 4 KIM DENNIS D ZFGN Common Stock S - Sale D 40,0000 -593 -24 0
2015-09-16 2015-09-14 4 KIM DENNIS D ZFGN Common Stock M - Exercise D 1,5700 593 1 593
2015-07-24 2015-07-23 4 STARR KEVIN P ZFGN Common Stock J - Other D 99.351 271.489
2015-07-24 2015-07-23 4 STARR KEVIN P ZFGN Common Stock J - Other I -479.081 0
2015-07-24 2015-07-23 4 STARR KEVIN P ZFGN Common Stock J - Other I 479.081 479.081
2015-07-24 2015-07-23 4 STARR KEVIN P ZFGN Common Stock J - Other I -1.200.000 2.002.045
2015-07-24 2015-07-23 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D -479.081 0
2015-07-24 2015-07-23 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D 479.081 479.081
2015-07-24 2015-07-23 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D -1.200.000 2.002.045
2015-07-15 2015-07-13 4 STARR KEVIN P ZFGN Stock Option (Right to Buy) A - Award D 37,15 12.000 12.000
2015-07-15 2015-07-13 4 Goldberg Avi Y. ZFGN Stock Option (Right to Buy) A - Award D 37,15 12.000 12.000
2015-07-15 2015-07-13 4 Barrett Peter ZFGN Stock Option (Right to Buy) A - Award D 37,15 12.000 12.000
2015-07-15 2015-07-13 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 37,15 12.000 12.000
2015-07-15 2015-07-13 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 37,15 12.000 12.000
2015-07-15 2015-07-13 4 Booth Bruce ZFGN Stock Option (Right to Buy) A - Award D 37,15 12.000 12.000
2015-07-15 2015-07-13 4 Heller Frances K ZFGN Stock Option (Right to Buy) A - Award D 37,15 12.000 12.000
2015-06-12 2015-06-10 4 Goldberg Avi Y. ZFGN Common Stock S - Sale D 35,0000 -3.000 -105 58.734
2015-06-03 2015-06-01 4 Goldberg Avi Y. ZFGN Common Stock S - Sale D 32,2262 -2.000 -64 61.734
2015-05-18 2015-05-15 4 STARR KEVIN P ZFGN Common Stock J - Other D 92.041 172.138
2015-05-18 2015-05-15 4 STARR KEVIN P ZFGN Common Stock J - Other I -443.935 0
2015-05-18 2015-05-15 4 STARR KEVIN P ZFGN Common Stock J - Other I 443.935 443.935
2015-05-18 2015-05-15 4 STARR KEVIN P ZFGN Common Stock J - Other I -1.000.000 3.202.045
2015-05-18 2015-05-15 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D -443.935 0
2015-05-18 2015-05-15 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D 443.935 443.935
2015-05-18 2015-05-15 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D -1.000.000 3.202.045
2015-03-26 2015-03-24 4 Atlas Venture Fund VII L P ZFGN Common Stock J - Other D -1.000.000 4.632.730
2015-03-25 2015-03-24 4 STARR KEVIN P ZFGN Common Stock J - Other D 71.989 80.097
2015-03-25 2015-03-24 4 STARR KEVIN P ZFGN Common Stock J - Other I -346.658 0
2015-03-25 2015-03-24 4 STARR KEVIN P ZFGN Common Stock J - Other I 346.658 346.658
2015-03-25 2015-03-24 4 STARR KEVIN P ZFGN Common Stock J - Other I -1.400.000 4.202.045
2015-03-25 2015-03-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D -346.658 0
2015-03-25 2015-03-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D 346.658 346.658
2015-03-25 2015-03-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock J - Other D -1.400.000 4.202.045
2015-03-19 2015-03-17 4 Hughes Thomas E. ZFGN Stock Option (Right to Buy) A - Award D 45,57 180.000 180.000
2015-03-03 2015-02-27 4 Allen Patricia L ZFGN Stock Option (Right to Buy) A - Award D 38,65 60.000 187.388
2015-03-03 2015-02-27 4 KIM DENNIS D ZFGN Stock Option (Right to Buy) A - Award D 38,65 90.000 281.509
2015-03-03 2015-02-27 4 Secor Alicia ZFGN Stock Option (Right to Buy) A - Award D 38,65 60.000 219.235
2015-03-03 2015-02-27 4 Loustau Patrick ZFGN Stock Option (Right to Buy) A - Award D 38,65 45.000 324.777
2015-01-12 2015-01-08 4 Booth Bruce ZFGN Common Stock A - Award D 40,0400 874 35 5.633.604
2015-01-12 2015-01-08 4 STARR KEVIN P ZFGN Common Stock A - Award D 40,0400 1.248 50 9.356
2015-01-12 2015-01-08 4 Barrett Peter ZFGN Common Stock A - Award D 40,0400 1.748 70 5.634.478
2015-01-12 2015-01-08 4 LAMATTINA JOHN L ZFGN Stock Option (Right to Buy) A - Award D 40,04 1.593 9.554
2014-11-03 2014-10-30 4 Heller Frances K ZFGN Stock Option (Right to Buy) A - Award D 21,34 13.327 13.327
2014-06-26 2014-06-24 4 THOMAS FRANK E ZFGN Stock Option (Right to Buy) A - Award D 16,00 13.327 13.327
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Series D Preferred Stock C - Conversion I -4.666.478 0
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Series C Preferred Stock C - Conversion I -8.263.595 0
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Series B Preferred Stock C - Conversion I -22.250.770 0
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Common Stock C - Conversion I 743.070 5.610.153
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Common Stock C - Conversion I 1.315.859 4.867.083
2014-06-26 2014-06-24 4 STARR KEVIN P ZFGN Common Stock C - Conversion I 3.543.116 3.551.224
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Series D Preferred Stock C - Conversion I -4.690.696 0
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Series C Preferred Stock C - Conversion I -8.263.595 0
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Series B Preferred Stock C - Conversion I -17.651.253 0
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Series A Preferred Stock C - Conversion I -4.768.001 0
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Common Stock C - Conversion I 746.926 5.632.730
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Common Stock C - Conversion I 1.315.859 4.885.804
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Common Stock C - Conversion I 2.810.709 3.569.945
2014-06-26 2014-06-24 4 Barrett Peter ZFGN Common Stock C - Conversion I 759.236 759.236
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Series D Preferred Stock C - Conversion D -4.690.696 0
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Series C Preferred Stock C - Conversion D -8.263.595 0
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Series B Preferred Stock C - Conversion D -17.651.253 0
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Series A Preferred Stock C - Conversion D -4.768.001 0
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Common Stock C - Conversion D 746.926 5.632.730
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Common Stock C - Conversion D 1.315.859 4.885.804
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Common Stock C - Conversion D 2.810.709 3.569.945
2014-06-26 2014-06-24 4 Atlas Venture Fund VII L P ZFGN Common Stock C - Conversion D 759.236 759.236
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Series D Preferred Stock C - Conversion I -4.690.696 0
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Series C Preferred Stock C - Conversion I -8.263.595 0
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Series B Preferred Stock C - Conversion I -17.651.253 0
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Series A Preferred Stock C - Conversion I -4.768.001 0
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Common Stock C - Conversion I 746.926 5.632.730
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Common Stock C - Conversion I 1.315.859 4.885.804
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Common Stock C - Conversion I 2.810.709 3.569.945
2014-06-26 2014-06-24 4 Booth Bruce ZFGN Common Stock C - Conversion I 759.236 759.236
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Series D Preferred Stock C - Conversion D -4.666.478 0
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Series C Preferred Stock C - Conversion D -8.263.595 0
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Series B Preferred Stock C - Conversion D -22.250.770 0
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock C - Conversion D 743.070 5.602.045
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock C - Conversion D 1.315.859 4.858.975
2014-06-26 2014-06-24 4 THIRD ROCK VENTURES LP ZFGN Common Stock C - Conversion D 3.543.116 3.543.116
2014-06-26 2014-06-24 4 Loustau Patrick ZFGN Stock Option (Right to Buy) A - Award D 16,00 279.777 279.777
2014-06-23 2014-06-19 4 Secor Alicia Held by Spouse ZFGN Common Stock P - Purchase I 20,0000 4.000 80 4.000
2014-06-18 3 STARR KEVIN P ZFGN Common Stock D 16.216
2014-06-18 3 STARR KEVIN P ZFGN Common Stock D 16.216
2014-06-18 3 Hughes Thomas E. ZFGN Common Stock D 70.506
2014-06-18 3 Hughes Thomas E. ZFGN Common Stock D 70.506
2014-06-18 3 Goldberg Avi Y. ZFGN Common Stock I 695.284
2014-06-18 3 Goldberg Avi Y. ZFGN Common Stock I 695.284
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:ZA71 2,80 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2026 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Features
Explore
Help Center